1.  57
    Patient expectations of benefit from phase I clinical trials: Linguistic considerations in diagnosing a therapeutic misconception.K. P. Weinfurt, Daniel P. Sulmasy, Kevin A. Schulman & Neal J. Meropol - 2003 - Theoretical Medicine and Bioethics 24 (4):329-344.
    The ethical treatment of cancer patientsparticipating in clinical trials requiresthat patients are well-informed about thepotential benefits and risks associated withparticipation. When patients enrolled in phaseI clinical trials report that their chance ofbenefit is very high, this is often taken as evidence of a failure of the informed consent process. We argue, however, that some simple themes from the philosophy of language may make such a conclusion less certain. First, the patient may receive conflicting statements from multiple speakers about the expected (...)
    Direct download (3 more)  
    Export citation  
    Bookmark   12 citations  
  2.  21
    Community hospital oversight of clinical investigators' financial relationships.M. A. Hall, K. P. Weinfurt, J. S. Lawlor, J. Y. Friedman, K. A. Schulman & J. Sugarman - 2008 - IRB: Ethics & Human Research 31 (1):7-13.
    The considerable attention to financial interests in clinical research has focused mostly on academic medical centers, even though the majority of clinical research is conducted in community practice settings. To fill this gap, this article maps the practices and policies in 73 community hospitals and several hundred specialized facilities around the country for reviewing clinical investigators’ financial relationships with research sponsors. Community hospitals face a substantially different mix of issues than academic medical centers do because their physician researchers are usually (...)
    Direct download (4 more)  
    Export citation  
    Bookmark   3 citations  
  3.  18
    Developing model language for disclosing financial interests to potential clinical research participants.K. P. Weinfurt, J. S. Allsbrook, J. Y. Friedman, M. A. Dinan, M. A. Hall, K. A. Schulman & J. Sugarman - 2006 - IRB: Ethics & Human Research 29 (1):1-5.
    As part of a larger research study, we present model language for disclosing financial interests in clinical research to potential research participants, and we describe the empirical basis and theoretical assumptions used in developing the language. The empirical process for creating appropriate disclosure language resulted in a generic disclosure statement for cases in which no risk to participants’ welfare or the scientific integrity of the research is expected, and nine more specific disclosure statements for cases in which some risk is (...)
    Direct download (5 more)  
    Export citation